Innealta Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Innealta Capital’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-41	Closed	-$631	–	1387
2024 Q2	$631	Buy	+41	New	+$586	﹤0.01%	1427

Other funds holding SBRA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Innealta Capital's SBRA Position: Q3 2024 in Review

Innealta Capital sold out of Sabra Healthcare REIT (SBRA) in Q3 2024, closing a stake of 41 shares — an estimated $631 sold.

Innealta Capital first reported a position in SBRA in Q2 2024 and held it in 1 quarter. The position peaked at $631 in Q2 2024. 379 funds tracked by Wall St. Rank hold SBRA as of Q3 2024.

Innealta Capital reported no remaining Sabra Healthcare REIT position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 41 Sabra Healthcare REIT shares in Q3 2024, an estimated $631.
Innealta Capital first reported a position in Sabra Healthcare REIT in Q2 2024 and held it in 1 quarter.
Innealta Capital's Sabra Healthcare REIT position peaked at $631 in Q2 2024.
379 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.